TORONTO, Oct. 30 (GenomeWeb News) - GE Healthcare will launch its overdue 16-chamber rat ADME assay for the CodeLink platform by the middle of November, Lisa D'Anzi, marketing director for the platform, said yesterday at the American Society of Human Genetics 54th annual meeting.
"The assay will launch toward the end of next week or the beginning of the following," pending the completion of last-minute data, said D'Anzi. She made the remarks following a GE Healthcare-sponsored CodeLink workshop that occurred here yesterday during the ASHG meeting, held here last week.
BioArray News, GenomeWeb News' sister publication, reported in early June that the company originally intended to introduce the ADME-Rat 16 assay within 60 to 90 days - that is, before September.
The assay was to be the first produced for the CodeLink platform after GE Healthcare acquired Amersham in April. Instead, the whole mouse genome assay, which launches next week, will become the platform's first. D'Anzi said GE Healthcare was "already selling" whole mouse genome assays.